Laboratory Animal Models, 3D Cultures and Organoids

Report Code: PHM204A

Publish Date: Apr 2019

Publisher: BCC Publishing

Category: Pharmaceuticals

Customize This Report

EXPLORE OFFERS

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

The global market for laboratory animal models should grow from $5.9 billion in 2018 to $7.8 billion by 2023, increasing at a compound annual growth rate (CAGR) of 5.6% for the period of 2018-2023.

Report Includes

  • 49 data tables 16 additional tables
  • Comprehensive overview of the global markets for laboratory animal models, 3D cell cultures and organoids
  • Analyses of global market trends, with data from 2016, 2017 and 2018; estimates for 2019 to 2022; and projections of compound annual growth rates (CAGRs) through 2023
  • Country specific data and analysis for Australia, China, Japan, U.S., Canada, Mexico, Brazil, U.K., France, Germany, Israel and Middle East
  • Information on current trends that significantly affect the basic research, biomedical and other industries where animals are used for toxicity testing and for evaluating the safety and metabolism of chemical compounds
  • Discussion of most significant trends in the 3D cell culture industry, including the bioprinting, organ-on-chip and organoid segments
  • Review of selected patents and patent applications on laboratory animal models for a brief period of 2006 to 2018
  • Company profiles of major market players within the industry, including Charles River Laboratories, Envigo, Crown Bioscience Inc., Genoway S.A., Taconic Biosciences and Merck & Co., Inc.

Report Scope

The report describes three global markets: the animal model market, the 3D cultures market and the organoid market. The organoid market is described in more detail in a separate chapter of the report.

Analyst Credentials

Martin Kubeš is a market research expert with a Master's Degree in Molecular Biology and Genetics. In these fields, he has five years of laboratory practice experience, mainly in immunology and cancer research. His market research background includes performing custom ad-hoc studies for some of the biggest chemical and breeder companies and their subsidiaries. He has experience with both local and global studies, based either on desk research or on both qualitative and quantitative market research approaches.

Need a custom data table, graph, region, segment, companies or complete report? CUSTOMIZE NOW
Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Laboratory Animal Models, 3D Cultures and Organoids198Free
Chapter- 1: Introduction5Free
Chapter- 2: Summary and Highlights3Free
Chapter- 3: Animal Model Market Technology Background32Free
Chapter- 4: 3D Cell Cultures Market Breakdown by Technology39Free
Chapter- 5: Organoids Market Breakdown by Technology19Free
Chapter- 6: Market Breakdown by End User12Free
Chapter- 7: Market Breakdown by Application7Free
Chapter- 8: Market Breakdown by Region28Free
Chapter- 9: Patent Review/New Developments6Free
Chapter- 10: Analysis of Market Opportunities8Free
Chapter- 11: Profiles of Companies and Important Institutions39Free

Related Reports

Global Market for Contract Research Organization (CRO) Services

Published - Oct 2024 | Publisher - BCC Publishing | Code - PHM186C

The global market for contract research organization (CRO) services is expected to grow from $111.8 billion in 2024 and is projected to reach $166.0 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.2% during the forecast period of 2024 to 2029.

3D Cell Cultures: Technologies and Global Markets

Published - Mar 2024 | Publisher - BCC Publishing | Code - BIO140D

The global market for 3D cell culture is estimated to increase from $4.6 billion in 2023 to reach $14.8 billion by 2028, at a compound annual growth rate (CAGR) of 26.5% from 2023 through 2028.

Global Market for Stem Cells

Published - Apr 2023 | Publisher - BCC Publishing | Code - BIO035H

The global stem cell market reached $32.1 billion in 2022 and should reach $65.6 billion by 2027, with a compound annual growth rate (CAGR) of 15.3% during the forecast period of 2022-2027.

Bioprinting: Technologies and Global Markets

Published - Feb 2023 | Publisher - BCC Publishing | Code - BIO148B

The global bioprinting technologies market should reach $5.0 billion by 2027 from $2.4 billion in 2022 at a compound annual growth rate (CAGR) of 16.2% for the forecast period of 2022 to 2027.

Recent Reports

Laboratory Animal Models, 3D Cultures, and Organoids: Global Markets

Published - Dec 2024 | Publisher - BCC Publishing | Code - PHM204C

The global market for laboratory animal models, 3D cultures, and organoids is estimated to increase from $2.8 billion in 2024 to reach $5.0 billion by 2029, at a compound annual growth rate (CAGR) of 12.5% from 2024 through 2029.

Rare Disease Diagnostics: Technologies and Global Markets

Published - Dec 2024 | Publisher - BCC Publishing | Code - PHM227B

The global market for rare disease diagnostics is estimated to increase from $21.6 billion in 2024 to reach $34.7 billion by 2029, at a compound annual growth rate (CAGR) of 9.9% from 2024 through 2029.

Breakthrough Therapies: Market Dynamics and Investment Opportunities

Published - Dec 2024 | Publisher - BCC Publishing | Code - PHM176B

The global market for breakthrough therapy drugs was valued at $133.3 billion in 2023. This market is expected to grow from $150.6 billion in 2024 to $287.5 billion by 2029, at a compound annual growth rate (CAGR) of 13.8% from 2024 to 2029.

Softgel Capsules: Global Markets

Published - Nov 2024 | Publisher - BCC Publishing | Code - PHM244B

The global market for softgel capsules was valued at $7.4 billion in 2023. The market is expected to grow from $7.9 billion in 2024 to $11.5 billion by 2029, at a compound annual growth rate, or CAGR, of 7.7% from 2024 through 2029.

Global Market Opportunities and Competitive Landscape for CDMO

Published - Nov 2024 | Publisher - BCC Publishing | Code - PHM238B

The global CDMO market was valued at $128.0 billion in 2023. This market is expected to grow from $136.6 billion in 2024 to $191.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2029.

Top Trending Reports

Single-use Technologies for Biopharmaceuticals: Global Markets

Published - Nov 2024 | Publisher - BCC Publishing | Code - BIO099F

The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.

Cell and Gene Therapy Tools, and Reagents: Global Markets

Published - Nov 2024 | Publisher - BCC Publishing | Code - BIO208C

The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.

Medical Devices Industry: Competitive Landscape

Published - Nov 2024 | Publisher - BCC Publishing | Code - MDS010C

The global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.

Global Market Opportunities and Competitive Landscape for CDMO

Published - Nov 2024 | Publisher - BCC Publishing | Code - PHM238B

The global CDMO market was valued at $128.0 billion in 2023. This market is expected to grow from $136.6 billion in 2024 to $191.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2029.

Chronic Disease Management: Therapeutics, Device Technologies and Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - HLC239C

The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Laboratory Animal Models, 3D Cultures and Organoids
Customize Report